One recent randomized controlled study by the NASH Clinical Research Network which compared pioglitazone, placebos, and Vitamin E showed improvement of steatohepatitis without any increase of fibrosis among patients who received 800 IUs of Vitamin E daily for two years.
Un estudio reciente, controlado y aleatorizado del NASH Clinical Research Network comparando pioglitazona, placebo y vitamina E mostró mejoría de la esteatohepatitis sin aumento de la fibrosis en los pacientes que recibieron por 2 años vitamina E 800 UI diarias.